Clinical Trials Browser

Differentiated Thyroid Cancer × surufatinib × Endocrine × Clear all

NCT05989425 2023-08-14

Surufatinib as Neoadjuvant Treatment for Locally Advanced or Metastatic Differentiated Thyroid Cancer

Phase 2 Recruiting

EndocrineHead & Neck

Differentiated Thyroid Cancer